Long-acting shot prevents HIV infection in animal studies

Two studies presented at the annual Conference on Retroviruses and Opportunistic Infections showed that a reformulated, long-acting injectable drug called GSK744 gave 100% protection to macaques from the hybrid simian/ human AIDS virus for up to three months against infection. Researchers from the University of Rockefeller and the Centers for Disease Control and Prevention tested the drug in a separate study in different doses on animal subjects, which gained similar positive results. Researchers expect to launch trials in the coming months to test if the drug will work on humans.

View Full Article in:

HealthDay News · New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Education

Job Title Company Location
CONTRACT - Education Consultants
Confidential
East Coast, Phoenix, Los Angeles, SL_Multiple Locations
Inside Sales Representative
Apperson, Inc.
Multiple Locations, SL_Multiple Locations
Product Marketing Manager
Apperson, Inc.
Charlotte, NC
Business Development Analyst
Insight Education Group
Los Angeles, CA
Instructional Designer, ESL
Imagine Learning, Inc.
Provo, UT